After documenting her life and bucket list on TikTok, influencer Maddy Baloy died of cancer at age 26 on May 2, 2024. One ...

In solid tumors, such as skin, lung, or bone and soft tissue cancer ... New Immune Boost Could Expand Access to Cancer Immunotherapy Apr. 11, 2025 — Researchers have found that tapping into the ...

Preventing this complication for those who receive a lung transplant is of the highest priority, as there ... Experimental Cancer Drug Could Streamline Standard Tuberculosis Treatment and Prevent ...

Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell lung cancer and non-small-cell lung cancer, according to the shape of cells ...

Opdivo (nivolumab) is a brand-name IV infusion prescribed for non-small cell lung cancer (NSCLC) in some situations. This article covers topics such as side effects, dosage, and how Opdivo works.

At this year’s American Association for Cancer Research (AACR) Annual Meeting in Chicago, the German drugmaker added durability and progression free survival (PFS) results to the breadth of data ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2-mutant non-small cell lung cancer (NSCLC) in a multicohort phase Ia/Ib ...

AstraZeneca’s hopes of positioning its PD-L1 inhibitor Imfinzi as a post-surgery therapy for people with earlier-stage lung cancer have taken a knock, although it performed well in a bladder ...

Researchers in the UK have developed a lung cancer cell line that they believe could be an important new tool for the discovery of new therapies for the disease. The team from Cancer Research UK's ...

that she's 'feeling pretty good' amid her cancer journey, noting that "half the time I'm strong, half the time I'm crying' The Real Housewives of Beverly Hills alum said her immunotherapy ...

Teddi Mellencamp is embracing the latest chapter of her ongoing cancer journey ... "Seeing my scars on my back and head make me cry but also remind me of all the things we can overcome." ...

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer in the US, accounting for approximately 85% of all cases. Two frequent genetic drivers of NSCLC progression are mutations ...